Literature DB >> 26297855

Massachusetts Alzheimer's Disease Research Center: progress and challenges.

Bradley T Hyman1, John H Growdon2, Mark W Albers2, Randy L Buckner3, Jasmeer Chhatwal2, Maria Teresa Gomez-Isla2, Christian Haass4, Eloise Hudry2, Clifford R Jack5, Keith A Johnson6, Zaven S Khachaturian7, Doo Yeon Kim2, Joseph B Martin8, Roger M Nitsch9, Bruce R Rosen10, Dennis J Selkoe11, Reisa A Sperling12, Peter St George-Hyslop13, Rudolph E Tanzi2, Liang Yap2, Anne B Young2, Creighton H Phelps14, Patricia G McCaffrey15.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26297855      PMCID: PMC4654956          DOI: 10.1016/j.jalz.2015.06.1887

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


× No keyword cloud information.
  24 in total

1.  Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Authors:  David T Chien; Shadfar Bahri; A Katrin Szardenings; Joseph C Walsh; Fanrong Mu; Min-Ying Su; William R Shankle; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.

Authors:  Chun-Fang Xia; Janna Arteaga; Gang Chen; Umesh Gangadharmath; Luis F Gomez; Dhanalakshmi Kasi; Chung Lam; Qianwa Liang; Changhui Liu; Vani P Mocharla; Fanrong Mu; Anjana Sinha; Helen Su; A Katrin Szardenings; Joseph C Walsh; Eric Wang; Chul Yu; Wei Zhang; Tieming Zhao; Hartmuth C Kolb
Journal:  Alzheimers Dement       Date:  2013-02-12       Impact factor: 21.566

3.  Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer's disease.

Authors:  Bin Zhang; Chris Gaiteri; Liviu-Gabriel Bodea; Zhi Wang; Joshua McElwee; Alexei A Podtelezhnikov; Chunsheng Zhang; Tao Xie; Linh Tran; Radu Dobrin; Eugene Fluder; Bruce Clurman; Stacey Melquist; Manikandan Narayanan; Christine Suver; Hardik Shah; Milind Mahajan; Tammy Gillis; Jayalakshmi Mysore; Marcy E MacDonald; John R Lamb; David A Bennett; Cliona Molony; David J Stone; Vilmundur Gudnason; Amanda J Myers; Eric E Schadt; Harald Neumann; Jun Zhu; Valur Emilsson
Journal:  Cell       Date:  2013-04-25       Impact factor: 41.582

4.  Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta.

Authors:  Ana Griciuc; Alberto Serrano-Pozo; Antonio R Parrado; Andrea N Lesinski; Caroline N Asselin; Kristina Mullin; Basavaraj Hooli; Se Hoon Choi; Bradley T Hyman; Rudolph E Tanzi
Journal:  Neuron       Date:  2013-04-25       Impact factor: 17.173

5.  ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.

Authors:  Jaehong Suh; Se Hoon Choi; Donna M Romano; Moira A Gannon; Andrea N Lesinski; Doo Yeon Kim; Rudolph E Tanzi
Journal:  Neuron       Date:  2013-09-19       Impact factor: 17.173

6.  Dissecting phenotypic traits linked to human resilience to Alzheimer's pathology.

Authors:  Beatriz G Perez-Nievas; Thor D Stein; Hwan-Ching Tai; Oriol Dols-Icardo; Thomas C Scotton; Isabel Barroeta-Espar; Leticia Fernandez-Carballo; Estibaliz Lopez de Munain; Jesus Perez; Marta Marquie; Alberto Serrano-Pozo; Mathew P Frosch; Val Lowe; Joseph E Parisi; Ronald C Petersen; Milos D Ikonomovic; Oscar L López; William Klunk; Bradley T Hyman; Teresa Gómez-Isla
Journal:  Brain       Date:  2013-07-03       Impact factor: 13.501

7.  Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.

Authors:  D S Knopman; C R Jack; H J Wiste; S D Weigand; P Vemuri; V Lowe; K Kantarci; J L Gunter; M L Senjem; R J Ivnik; R O Roberts; B F Boeve; R C Petersen
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

8.  Impaired default network functional connectivity in autosomal dominant Alzheimer disease.

Authors:  Jasmeer P Chhatwal; Aaron P Schultz; Keith Johnson; Tammie L S Benzinger; Clifford Jack; Beau M Ances; Caroline A Sullivan; Stephen P Salloway; John M Ringman; Robert A Koeppe; Daniel S Marcus; Paul Thompson; Andrew J Saykin; Stephen Correia; Peter R Schofield; Christopher C Rowe; Nick C Fox; Adam M Brickman; Richard Mayeux; Eric McDade; Randall Bateman; Anne M Fagan; Allison M Goate; Chengjie Xiong; Virginia D Buckles; John C Morris; Reisa A Sperling
Journal:  Neurology       Date:  2013-07-24       Impact factor: 9.910

9.  Staged decline of neuronal function in vivo in an animal model of Alzheimer's disease.

Authors:  Christine Grienberger; Nathalie L Rochefort; Helmuth Adelsberger; Horst A Henning; Daniel N Hill; Julia Reichwald; Matthias Staufenbiel; Arthur Konnerth
Journal:  Nat Commun       Date:  2012-04-10       Impact factor: 14.919

10.  Soluble γ-secretase modulators selectively inhibit the production of the 42-amino acid amyloid β peptide variant and augment the production of multiple carboxy-truncated amyloid β species.

Authors:  Steven L Wagner; Can Zhang; Soan Cheng; Phuong Nguyen; Xulun Zhang; Kevin D Rynearson; Rong Wang; Yueming Li; Sangram S Sisodia; William C Mobley; Rudolph E Tanzi
Journal:  Biochemistry       Date:  2014-01-22       Impact factor: 3.162

View more
  2 in total

1.  Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.

Authors:  Gregoire Boulouis; Andreas Charidimou; Michael J Jessel; Li Xiong; Duangnapa Roongpiboonsopit; Panagiotis Fotiadis; Marco Pasi; Alison Ayres; M Emily Merrill; Kristin M Schwab; Jonathan Rosand; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  Neurology       Date:  2017-01-27       Impact factor: 9.910

2.  Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.

Authors:  Li Xiong; Gregoire Boulouis; Andreas Charidimou; Duangnapa Roongpiboonsopit; Michael J Jessel; Marco Pasi; Yael D Reijmer; Panagiotis Fotiadis; Alison Ayres; Emily Merrill; Kristin Schwab; Deborah Blacker; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-20       Impact factor: 6.960

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.